Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β

Control of Metastases via Myeloid CD39 and NK Cell Effector Function

(2020) Juming Yan et al.   Cancer Immunology Research

Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression

(2019) Antonino Bruno et al.   Frontiers in Immunology

Natural Killer Cells in the Lungs

(2019) Jingjing Cong et al.   Frontiers in Immunology

Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF

(2019) Takanori Kitamura et al.   Cancer Immunology Research

Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells

(2019) Valentina Bonanni et al.   Journal for ImmunoTherapy of Cancer

Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models

(2019) Sarah Greene et al.   CLINICAL CANCER RESEARCH

CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal Xenografts

(2019) Yu Yang Ng et al.   Molecular Therapy-Oncolytics

Monocytes Differentiate to Immune Suppressive Precursors of Metastasis-Associated Macrophages in Mouse Models of Metastatic Breast Cancer

(2018) Takanori Kitamura et al.   Frontiers in Immunology

An antibody designed to improve adoptive NK-cell therapy inhibits pancreatic cancer progression in a murine model

(2018) Jaemin Lee et al.   Cancer Immunology Research

Tumour-associated macrophages as treatment targets in oncology

(2017) Alberto Mantovani et al.   Nature Reviews Clinical Oncology

The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy

(2017) Sourav Paul et al.   Frontiers in Immunology

Murine peripheral NK-cell populations originate from site-specific immature NK cells more than from BM-derived NK cells

(2016) Nissim Pinhas et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

M2-polarized and tumor-associated macrophages alter NK cell phenotype and function in a contact-dependent manner

(2016) Tamara Krneta et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Targeting natural killer cells in cancer immunotherapy

(2016) Camille Guillerey et al.   NATURE IMMUNOLOGY

Anti-programmed cell death protein-1/ligand-1 therapy in different cancers

(2015) B Homet Moreno et al.   BRITISH JOURNAL OF CANCER

The breast tumor microenvironment alters the phenotype and function of natural killer cells

(2015) Tamara Krneta et al.   Cellular & Molecular Immunology

CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages

(2015) Takanori Kitamura et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity

(2015) Carin I. M. Dahlberg et al.   Frontiers in Immunology

Effect of tumor cells and tumor microenvironment on NK-cell function

(2014) Massimo Vitale et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF- 1

(2014) H. Li et al.   JOURNAL OF IMMUNOLOGY

Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells

(2014) Dorothy K Sojka et al.   eLife

Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1

(2013) Yibing Xu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

NK cell-based immunotherapy for malignant diseases

(2013) Min Cheng et al.   Cellular & Molecular Immunology

NK Cell Response to Vaccinia Virus Is Regulated by Myeloid-Derived Suppressor Cells

(2012) C. Fortin et al.   JOURNAL OF IMMUNOLOGY

Defining GM-CSF- and Macrophage-CSF-Dependent Macrophage Responses by In Vitro Models

(2012) D. C. Lacey et al.   JOURNAL OF IMMUNOLOGY

Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer

(2012) Minu K. Srivastava et al.   PLoS One

Mouse Lung and Spleen Natural Killer Cells Have Phenotypic and Functional Differences, in Part Influenced by Macrophages

(2012) Tatiana Michel et al.   PLoS One

Clinical implication of HLA class I expression in breast cancer

(2011) Koichi Kaneko et al.   BMC CANCER

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Macrophage Binding to Receptor VCAM-1 Transmits Survival Signals in Breast Cancer Cells that Invade the Lungs

(2011) Qing Chen et al.   CANCER CELL

Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay

(2011) Boris V. Dons'koi et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Survival differences among women with de novo stage IV and relapsed breast cancer

(2010) S. Dawood et al.   ANNALS OF ONCOLOGY

Meta-analysis of lineage-specific gene expression signatures in mouse leukocyte populations

(2010) Neil A. Mabbott et al.   IMMUNOBIOLOGY

Activating and inhibitory receptors of natural killer cells

(2010) Hollie J Pegram et al.   IMMUNOLOGY AND CELL BIOLOGY

Granulocyte-colony-stimulatory factor: a strong inhibitor of natural killer cell function

(2010) Laura Schlahsa et al.   TRANSFUSION

Activin-A attenuates several human natural killer cell functions

(2009) N. C. Robson et al.   BLOOD

Maturation of mouse NK cells is a 4-stage developmental program

(2009) L. Chiossone et al.   BLOOD

A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth

(2009) Binzhi Qian et al.   PLoS One